Charles Schwab’s Minerva Neurosciences NERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-78,969
| Closed | -$231K | – | 3497 |
|
|
2021
Q1 | $231K | Buy |
78,969
+220
| +0.3% | +$644 | ﹤0.01% | 3300 |
|
|
2020
Q4 | $185K | Hold |
78,749
| – | – | ﹤0.01% | 3265 |
|
|
2020
Q3 | $251K | Hold |
78,749
| – | – | ﹤0.01% | 3103 |
|
|
2020
Q2 | $285K | Buy |
78,749
+5,620
| +8% | +$20.3K | ﹤0.01% | 3067 |
|
|
2020
Q1 | $441K | Buy |
73,129
+139
| +0.2% | +$838 | ﹤0.01% | 2757 |
|
|
2019
Q4 | $519K | Buy |
72,990
+3,184
| +5% | +$22.6K | ﹤0.01% | 2807 |
|
|
2019
Q3 | $541K | Buy |
69,806
+1,358
| +2% | +$10.5K | ﹤0.01% | 2767 |
|
|
2019
Q2 | $386K | Hold |
68,448
| – | – | ﹤0.01% | 2930 |
|
|
2019
Q1 | $539K | Buy |
68,448
+2,881
| +4% | +$22.7K | ﹤0.01% | 2735 |
|
|
2018
Q4 | $442K | Hold |
65,567
| – | – | ﹤0.01% | 2809 |
|
|
2018
Q3 | $823K | Hold |
65,567
| – | – | ﹤0.01% | 2680 |
|
|
2018
Q2 | $541K | Buy |
65,567
+18,267
| +39% | +$151K | ﹤0.01% | 2779 |
|
|
2018
Q1 | $296K | Hold |
47,300
| – | – | ﹤0.01% | 2883 |
|
|
2017
Q4 | $287K | Sell |
47,300
-9,700
| -17% | -$58.9K | ﹤0.01% | 2889 |
|
|
2017
Q3 | $434K | Buy |
57,000
+22,400
| +65% | +$171K | ﹤0.01% | 2758 |
|
|
2017
Q2 | $307K | Hold |
34,600
| – | – | ﹤0.01% | 2853 |
|
|
2017
Q1 | $281K | Hold |
34,600
| – | – | ﹤0.01% | 2839 |
|
|
2016
Q4 | $407K | Buy |
34,600
+9,600
| +38% | +$113K | ﹤0.01% | 2725 |
|
|
2016
Q3 | $353K | Hold |
25,000
| – | – | ﹤0.01% | 2734 |
|
|
2016
Q2 | $256K | Buy |
+25,000
| New | +$256K | ﹤0.01% | 2843 |
|